[Management of convulsive status epilepticus in childhood]

Sarah Glatter1,2, Francesco Cardona2, Eugen Trinka3,4,5

  • 1Department of Pediatrics and Adolescent Medicine, Center for Rare and Complex Childhood Onset Epilepsies, Member of ERN EpiCARE, Medical University Vienna, Vienna, Austria.

PubMed

Insights

Prompt diagnosis and treatment of pediatric convulsive status epilepticus (PCSE) are crucial. A new structured approach and pocket card aim to improve care and prevent complications in this common pediatric emergency.

Area of Science:

  • Pediatric Emergency Medicine
  • Neurology
  • Critical Care

Background:

  • Convulsive status epilepticus (CSE) is a frequent pediatric emergency with escalating risks of complications and mortality over time.
  • Existing guidelines for structured pediatric CSE (PCSE) management are lacking compared to adult protocols.
  • Timely intervention is critical to improve outcomes in pediatric CSE.

Purpose of the Study:

  • To introduce a structured documentation and management process for pediatric CSE (PCSE).
  • To develop a practical tool (pocket card) for rapid diagnostics and treatment.
  • To harmonize treatment standards across prehospital and hospital settings to prevent refractory PCSE.

Main Methods:

  • Development of a continuous documentation process from symptom onset through intensive care admission.
  • Creation of a pocket card detailing structured diagnostic and therapeutic measures for PCSE.
  • Collaboration between pediatric and neurology departments across Austrian EpiCARE centers.

Main Results:

  • A comprehensive documentation system has been established to track pediatric CSE cases.
  • A pocket card provides accessible, standardized guidance for frontline medical personnel.
  • The initiative aims to standardize care and improve response times for pediatric emergencies.

Conclusions:

  • The presented concept facilitates a structured approach to pediatric CSE (PCSE) management.
  • Standardized protocols and tools are essential for timely and effective treatment of pediatric emergencies.
  • Harmonizing care aims to reduce the incidence of refractory PCSE and associated complications.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
916
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
902
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
831